Latest Drug Approvals news
FDA Approves Cabozantinib for Previously Treated Advanced Neuroendocrine Tumors
posted March 31st
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Blujepa for Uncomplicated Urinary Tract Infections
posted March 25th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Tremfya for Active Crohn Disease in Adults
posted March 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Related Articles
FDA Expands Indication of Dust Mite Allergy Drug to Include Young Children 
Time From Drug Approval to Reimbursement Longer in U.S. Than Some European Countries 
FDA Approves Generic Emflaza Oral Suspension for Duchenne Muscular Dystrophy Monthly Specialist Briefings
Stay Connected
